Caitlin Lowie

Caitlin Lowie

VP, Corporate Communications and Investor Relations

Ardelyx

Bio:

Caitlin Lowie

Vice President, Corporate Communications and Investor Relations

 

Caitlin Lowie has nearly 20 years of experience managing, directing and developing communications strategies for life sciences companies across a number of disease states. Caitlin currently serves as the Vice President of Corporate Communications and Investor Relations of Ardelyx, a commercial-stage biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines for patients with unmet medical needs. In her role, Caitlin oversees all internal and external communications, as well as investor relations. Prior to joining Ardelyx, Caitlin served as the Vice President of Communications and Investor Relations at Solid Biosciences, a preclinical-stage gene therapy company focused on neuromuscular and cardiac diseases. Prior to Solid, Caitlin served in communications and investor relations roles of increasing responsibility at companies including Stallergenes Greer, AngioDynamics and American Express.

 

Caitlin received a B.A. in Communications from Le Moyne College.